News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gergel Ivan P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/03/2020 |
4
| Gergel Ivan P. (Director) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Disposed/sold 7,813 options to buy
@ $4.44, valued at
$34.7k
Disposed/sold 10,000 options to buy
@ $3.93, valued at
$39.3k
Disposed/sold 10,000 options to buy
@ $4.06, valued at
$40.6k
Disposed/sold 10,000 options to buy
@ $0.8203, valued at
$8.2k
Disposed/sold 15,000 options to buy
@ $0.972, valued at
$14.6k
|
|
| 11/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2020 |
4
| Gergel Ivan P. (Director) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Granted 10,000 options to buy
@ $0.8203, valued at
$8.2k
|
|
| 04/15/2019 |
4
| Gergel Ivan P. (Director) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Granted 10,000 options to buy
@ $4.06, valued at
$40.6k
|
|
| 01/24/2019 |
4
| Gergel Ivan P. (Director) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.93, valued at
$39.3k
|
|
| 12/17/2018 |
4
| Gergel Ivan P. (Director) has filed a Form 4 on Neurotrope, Inc.|
Txns:
| Granted 7,813 options to buy
@ $4.44, valued at
$34.7k
|
|
| 12/17/2018 |
3
| Gergel Ivan P. (Director) has filed a Form 3 on Neurotrope, Inc. |
| 11/28/2018 |
4
| Gergel Ivan P. (Director) has filed a Form 4 on Corium International, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $5.79, valued at
$115.8k
Disposed/sold 12,000 options to buy
@ $7.19, valued at
$86.3k
Disposed/sold 15,000 options to buy
@ $4.59, valued at
$68.9k
Disposed/sold 15,000 options to buy
@ $11.59, valued at
$173.9k
|
|
| 12/05/2017 |
4
| Gergel Ivan P. (Director) has filed a Form 4 on Corium International, Inc.|
Txns:
| Granted 15,000 options to buy
@ $11.59, valued at
$173.9k
|
|
| 11/17/2017 |
4
| Gergel Ivan P. (SVP & Chief Medical Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 20,000 shares
@ $0
Disposed/sold 5,022 shares
@ $44.23, valued at
$222.1k
Granted 50,000 options to buy
@ $14.41, valued at
$720.5k
|
|
| 10/03/2017 |
4
| Gergel Ivan P. (SVP & Chief Medical Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 43,296 shares
@ $24.04, valued at
$1M
Sold 56,704 shares
@ $24.21, valued at
$1.4M
Exercised 43,296 options to buy
@ $11.04, valued at
$478k
Exercised 56,704 options to buy
@ $11.04, valued at
$626k
|
|
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| Gergel Ivan P. (Director) has filed a Form 4 on Corium International, Inc. |
| 12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| Gergel Ivan P. (SVP & Chief Medical Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,685 shares
@ $17.56, valued at
$29.6k
|
|
| 07/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/18/2016 |
4
| Gergel Ivan P. (SVP & Chief Medical Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Exercised 1,250 shares
@ $0.0001, valued at
$0.1
Sold 556 shares
@ $11.92, valued at
$6.6k
Disposed/sold 1,250 restricted stock units
@ $0.0001, valued at
$0.1 |
|
| 02/05/2016 |
4
| Gergel Ivan P. (SVP & Chief Medical Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 100,000 options
@ $12.21, valued at
$1.2M
|
|
| 04/26/2013 |
4
| Gergel Ivan P. (EVP, R&D and CSO) has filed a Form 4 on ENDO HEALTH SOLUTIONS INC.|
Txns:
| Sold 12,500 shares
@ $36.48, valued at
$456k
Sold 61,206 shares
@ $36.46, valued at
$2.2M
Sold 31,484 shares
@ $36.48, valued at
$1.1M
Sold 33,035 shares
@ $36.41, valued at
$1.2M
Exercised 12,500 options to buy
@ $25.02, valued at
$312.8k
Exercised 61,206 options to buy
@ $19.93, valued at
$1.2M
Exercised 31,484 options to buy
@ $20.61, valued at
$648.9k
|
|
| 03/15/2013 |
4
| Gergel Ivan P. (EVP, Research & Development) has filed a Form 4 on ENDO HEALTH SOLUTIONS INC.|
Txns:
| Granted 15,952 shares
@ $0 |
|
| 02/28/2013 |
4
| Gergel Ivan P. (EVP, Research & Development) has filed a Form 4 on ENDO HEALTH SOLUTIONS INC.|
Txns:
| Paid exercise price by delivering 1,573 shares
@ $28.09, valued at
$44.2k
Paid exercise price by delivering 1,509 shares
@ $28.09, valued at
$42.4k
Paid exercise price by delivering 7,168 shares
@ $30.03, valued at
$215.3k
|
|
| 01/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2012 |
4
| Gergel Ivan P. (EVP, Research & Development) has filed a Form 4 on ENDO PHARMACEUTICALS HOLDINGS INC|
Txns:
| Granted 13,441 shares
@ $0
Paid exercise price by delivering 1,024 shares
@ $34.79, valued at
$35.6k
Granted 44,250 options to buy
@ $34.7, valued at
$1.5M
|
|
| 05/04/2011 |
4
| Gergel Ivan P. (EVP, Research & Development) has filed a Form 4 on ENDO PHARMACEUTICALS HOLDINGS INC|
Txns:
| Sold 12,500 shares
@ $39.39, valued at
$492.4k
Exercised 12,500 options to buy
@ $25.02, valued at
$312.8k
|
|
| 03/03/2011 |
4
| Gergel Ivan P. (EVP, Research & Development) has filed a Form 4 on ENDO PHARMACEUTICALS HOLDINGS INC|
Txns:
| Sold 30,603 shares
@ $35.77, valued at
$1.1M
Exercised 30,603 options to buy
@ $19.93, valued at
$609.9k
|
|
| 02/25/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/07/2010 |
4
| Gergel Ivan P. (EVP, Research & Development) has filed a Form 4 on ENDO PHARMACEUTICALS HOLDINGS INC|
Txns:
| Sold 25,000 shares
@ $36.53, valued at
$913.3k
Sold 30,603 shares
@ $36.53, valued at
$1.1M
Exercised 25,000 options to buy
@ $25.02, valued at
$625.5k
Exercised 30,603 options to buy
@ $19.93, valued at
$609.9k
|
|
| 02/23/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|